MORE►
Novartis
Gradalis CEO Steven Weinstein [Photo: Gradalis]
Biotech Co. Gradalis Names Former Novartis Exec as Its New CEO
by Sandra Engelland | Jan 14, 2026
With more than two decades of experience in life sciences leadership, venture capital, and company building, Steven Weinstein brings a track record of guiding innovative healthcare organizations from early-stage development through commercialization, Carrollton-based Gradalis said.
by Quincy Preston |
Sep 1, 2023
Tarleton State University received the go-ahead for a new biotechnology institute as part of Texas A&M-Fort Worth’s burgeoning downtown research campus.
Approved in mid-August by the Texas A&M University System Board of Regents, the biotech institute is situated in one of the nation’s fastest-growing life sciences hubs....
MORE►
by Dallas Innovates | Staff Report |
Nov 30, 2022
“The advantage of our algorithm is that it could screen about 100,000 compounds in a couple of days, which is much faster than other methods,” UT Dallas' Dr. Baris Coskunuzer says.
MORE►
by Jeff Bounds |
Jan 21, 2020
Alcon gave rise to a startup ecosystem in North Texas that is spreading into all parts of how drugs, medical devices, and more are created.
MORE►
[Photo by Delpixars via iStock]
New Details Released in Novartis’ Purchase of Encore Vision
by Nicholas Sakelaris | Jan 27, 2017
The Swiss pharmaceutical company paid $465 million for the Fort Worth eye care startup.
MORE►
by Lance Murray |
Dec 21, 2016
The company as developed a treatment for presbyopia, which can make it difficult for people to focus their eyes.
MORE►
by Nicholas Sakelaris |
Jul 11, 2016
The MD-10 is the world’s first certified hospital aircraft developed by Orbis, a nonprofit that fights blindness around the world.
MORE►
